Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Dacarbazine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 68 Hodgkin Disease 49 Lymphoma 19 Sarcoma 13 Neoplasm Metastasis 10 Leiomyosarcoma 8 Skin Neoplasms 6 Neoplasms 6 Uveal Melanoma 5 Sarcoma, Synovial 3 Recurrence 3 Solitary Fibrous Tumors 2 Sarcoma, Alveolar Soft Part 2 Neuroblastoma 2 Thyroid Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Parathyroid Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Melanoma Neoplasms 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Liposarcoma 1

Interventions

Cisplatin 46 Carboplatin 43 pembrolizumab 39 Paclitaxel 38 Gemcitabine 27 Radiotherapy 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 17 Cetuximab 16 Specimen Handling 15 Nivolumab 15 Cyclophosphamide 14 durvalumab 13 Fluorouracil 13 Sorafenib 10 Bevacizumab 10 130-nm albumin-bound paclitaxel 10 Sunitinib 9 Platinum 9 osimertinib 8 Radiation 8 Oxaliplatin 8 Irinotecan 8 Everolimus 8 Capecitabine 8 1,2-diaminocyclohexaneplatinum II citrate 8 Ipilimumab 7 Drug Therapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00070642 2009-02-10

CPG 7909 Injection in Melanoma

Pfizer

Phase 2 Completed

Carcinoma, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡